By Peter A. McCullough, MD, MPH
Please enjoy this continuing medical education lecture delivered at 40th Cellular Detoxification Conference sponsored by International College of Integrative Medicine in Indianapolis, Indianana, on September 7 2024.
There are no medicine grand rounds or primary care conferences addressing this topic. It is a white space in medicine where no academic medical center has a fundamental approach to handling about 5-10% of the population suffering from post-acute sequalae after recurrent SARS-CoV-2 infection or COVID-19 infection. Both load the body with pathogenic Spike protein which incites inflammation, oxidative stress, coagulation, and all the downstream effects that result in symptoms.
Because I have taken the ultimate accountability for McCullough Protocol Base Spike Detoxification (BSD) by publishing and copyrighting it in my own name, I can tell you first hand I get feedback about perceived safety and efficacy on a regular basis from all over the world. I am pleased to report that responses indicate this is the best approach for now until there are large, prospective, double-blind placebo controlled randomized trials of combinations of agents that measure meaningful outcomes. To my knowledge, no such trials have been planned as of yet. A search for long-COVID studies testing nattokinase, one of the principal components of BSD, found no records.
Please subscribe to Courageous Discourse as a paying ($5 monthly) or founder member so we can continue to bring you the truth.
Peter A. McCullough, MD, MPH
President, McCullough Foundation
McCullough Protocol Base Spike Detoxification